Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.

Literature DB >> 30021779

A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.

Srila Gopal¹, Qing Lu¹, Joshua J Man¹, Wendy Baur¹, Sitara P Rao¹, Lev Litichevskiy², Malvina Papanastasiou², Amanda L Creech², Katherine C DeRuff², James Mullahoo², Adam Officer², Shawn B Egri², Desiree Davison², Jacob D Jaffe², Iris Z Jaffe¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 30021779 PMCID： PMC6058230 DOI： 10.1182/bloodadvances.2018020396

Source DB: PubMed Journal: Blood Adv ISSN： 2473-9529

× No keyword cloud information.

25 in total

1. Comparative gene marker selection suite.

Authors: Joshua Gould; Gad Getz; Stefano Monti; Michael Reich; Jill P Mesirov
Journal: Bioinformatics Date: 2006-05-18 Impact factor: 6.937

2. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.

Authors: Dale K Shumaker; Thomas Dechat; Alexander Kohlmaier; Stephen A Adam; Matthew R Bozovsky; Michael R Erdos; Maria Eriksson; Anne E Goldman; Satya Khuon; Francis S Collins; Thomas Jenuwein; Robert D Goldman
Journal: Proc Natl Acad Sci U S A Date: 2006-05-31 Impact factor: 11.205

3. Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.

Authors: Jennifer G Abelin; Jinal Patel; Xiaodong Lu; Caitlin M Feeney; Lola Fagbami; Amanda L Creech; Roger Hu; Daniel Lam; Desiree Davison; Lindsay Pino; Jana W Qiao; Eric Kuhn; Adam Officer; Jianxue Li; Susan Abbatiello; Aravind Subramanian; Richard Sidman; Evan Snyder; Steven A Carr; Jacob D Jaffe
Journal: Mol Cell Proteomics Date: 2016-02-24 Impact factor: 5.911

4. Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner.

Authors: Anna Kreutzman; Beatriz Colom-Fernández; Ana Marcos Jiménez; Mette Ilander; Carlos Cuesta-Mateos; Yaiza Pérez-García; Cristina Delgado Arévalo; Oscar Brück; Henna Hakanen; Jani Saarela; Alvaro Ortega-Carrión; Ana de Rosendo; Alba Juanes-García; Juan Luis Steegmann; Satu Mustjoki; Miguel Vicente-Manzanares; Cecilia Muñoz-Calleja
Journal: Clin Cancer Res Date: 2017-08-18 Impact factor: 12.531

5. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.

Authors: Matthew R G Taylor; Dobromir Slavov; Andreas Gajewski; Sylvia Vlcek; Lisa Ku; Pamela R Fain; Elisa Carniel; Andrea Di Lenarda; Gianfranco Sinagra; Mark M Boucek; Jean Cavanaugh; Sharon L Graw; Patsy Ruegg; Jennie Feiger; Xiao Zhu; Debra A Ferguson; Michael R Bristow; Josef Gotzmann; Roland Foisner; Luisa Mestroni
Journal: Hum Mutat Date: 2005-12 Impact factor: 4.878

Review 6. Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML.

Authors: Peter Valent; Emir Hadzijusufovic; Gregor Hoermann; Wolfgang Füreder; Gerit-Holger Schernthaner; Wolfgang R Sperr; Rudolf Kirchmair; Dominik Wolf
Journal: Leuk Res Date: 2017-05-12 Impact factor: 3.156

7. Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.

Authors: Jorge E Cortes; H Jean Khoury; Hagop Kantarjian; Tim H Brümmendorf; Michael J Mauro; Ewa Matczak; Dmitri Pavlov; Jean M Aguiar; Kolette D Fly; Svetoslav Dimitrov; Eric Leip; Mark Shapiro; Jeff H Lipton; Jean-Bernard Durand; Carlo Gambacorti-Passerini
Journal: Am J Hematol Date: 2016-04-13 Impact factor: 10.047

8. A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.

Authors: Lev Litichevskiy; Ryan Peckner; Jennifer G Abelin; Jacob K Asiedu; Amanda L Creech; John F Davis; Desiree Davison; Caitlin M Dunning; Jarrett D Egertson; Shawn Egri; Joshua Gould; Tak Ko; Sarah A Johnson; David L Lahr; Daniel Lam; Zihan Liu; Nicholas J Lyons; Xiaodong Lu; Brendan X MacLean; Alison E Mungenast; Adam Officer; Ted E Natoli; Malvina Papanastasiou; Jinal Patel; Vagisha Sharma; Courtney Toder; Andrew A Tubelli; Jennie Z Young; Steven A Carr; Todd R Golub; Aravind Subramanian; Michael J MacCoss; Li-Huei Tsai; Jacob D Jaffe
Journal: Cell Syst Date: 2018-04-11 Impact factor: 10.304

9. Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.

Authors: Jonathan Douxfils; Hélène Haguet; François Mullier; Christian Chatelain; Carlos Graux; Jean-Michel Dogné
Journal: JAMA Oncol Date: 2016-05-01 Impact factor: 31.777

Review 10. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.

Authors: Simona Soverini; Manuela Mancini; Luana Bavaro; Michele Cavo; Giovanni Martinelli
Journal: Mol Cancer Date: 2018-02-19 Impact factor: 27.401

4 in total